These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31731312)

  • 1. [Not Available].
    Bollheimer C
    Drug Res (Stuttg); 2019 Nov; 69(S 01):S29-S30. PubMed ID: 31731312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
    Marx N
    Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
    Martin S
    Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
    [No Abstract]   [Full Text] [Related]  

  • 4. Is glucose control important for prevention of cardiovascular disease in diabetes?
    Mannucci E; Dicembrini I; Lauria A; Pozzilli P
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S259-63. PubMed ID: 23882055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basal insulin has a "neutral effect" on cardiovascular events].
    Overbeck P
    MMW Fortschr Med; 2012 Jun; 154(12):24. PubMed ID: 22880290
    [No Abstract]   [Full Text] [Related]  

  • 6. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-load hyperglycaemia-an inappropriate therapeutic target.
    Yudkin JS
    Lancet; 2002 Jan; 359(9301):166-7. PubMed ID: 11809285
    [No Abstract]   [Full Text] [Related]  

  • 9. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Chernikova NA
    Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A search for novel pathways of effective prevention of cardiovascular complications in patients with type 2 diabetes mellitus: advance trial].
    Karpov IuA; Shubina AT
    Kardiologiia; 2007; 47(10):90-5. PubMed ID: 18260953
    [No Abstract]   [Full Text] [Related]  

  • 13. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
    Einecke D
    MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 15. Concerns about meta-analysis of glucose control and cardiovascular disease in type 2 diabetes.
    Yudkin JS; Richter B
    Ann Intern Med; 2010 Jan; 152(1):63; author reply 63-4. PubMed ID: 20048277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved knowledge of antidiabetic treatment--a necessity for the modern cardiologist.
    Wikström G; Malmberg K; Rydén L
    Eur Heart J; 1999 Mar; 20(6):403-5. PubMed ID: 10213343
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin: a multitasking medication.
    Bailey CJ
    Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes.
    Ganda OP
    Cleve Clin J Med; 2016 May; 83(5 Suppl 1):S11-7. PubMed ID: 27176677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The extra-glycemic effects of liraglutide: focus on cardiometabolic markers].
    Giglio RV; Patti AM; Nikolic D; Castellino G; Noto M; Parrino A; Montalto G; Rizzo M
    G Ital Cardiol (Rome); 2016 Apr; 17(4):253-8. PubMed ID: 27093208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL.
    Torekov SS
    Cardiovasc Res; 2018 Aug; 114(10):e70-e71. PubMed ID: 30052921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.